These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 22193836)

  • 1. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
    Solomon MD; Ullal AJ; Hoang DD; Freeman JV; Heidenreich P; Turakhia MP
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):86-96. PubMed ID: 22193838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention in atrial fibrillation: an update on current management strategies.
    Hall T; Stanton T; Wang WY; Ng AC
    Panminerva Med; 2013 Mar; 55(1):43-58. PubMed ID: 23474663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
    Gibson DN; Price MJ; Ahern TS; Teirstein PS
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
    Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
    Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical closure devices for atrial fibrillation.
    Price MJ; Holmes DR
    Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Exclusion for Atrial Fibrillation.
    Syed FF; DeSimone CV; Friedman PA; Asirvatham SJ
    Heart Fail Clin; 2016 Apr; 12(2):273-97. PubMed ID: 26968671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: preventing thromboembolism and choosing nondrug therapies.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jul; 53(7):53-60. PubMed ID: 9672497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
    Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
    Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: epidemiology, prognosis and therapy.
    Rutzen-Lopez H; Khanna V; Reynolds MR
    Minerva Med; 2011 Jun; 102(3):187-207. PubMed ID: 21593721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of the left atrial appendage for thromboembolic prevention in atrial fibrillation.
    Faustino A; Paiva L; Providência R; Cação R; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Apr; 32(4):311-23. PubMed ID: 23528437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.